Fabric Genomics

Primary contact

Fabric Genomics, formerly Omicia, is developing tools that enable scientists to quickly and accurately process and analyze whole genomes, exomes and gene panels. The company's genomic data processing and advanced algorithmic tools have been licensed by over 1,000 commercial clinical laboratories, hospital core labs, country sequencing programs, and research institutions in more than 50 countries. Fabric Genomics can complete genetic analysis of whole genomes in less than 1 hour; it supports genomic data analysis, interpretation and reporting for both hereditary diseases and oncology. For health systems, the company's tools can easily integrate with hospital EMRs to deliver actionable genomic results within physician workflow at point-of-care. On the other hand, its BioGraph technology enables and supports the creation of population-specific reference genomes for novel diagnostics and drug discovery, clinical trial stratification, and research studies.
Primary contact

Funding 💰

Total $29.8M
Select investors Artis Ventures, Roche Venture Fund, UPMC, Ping An Ventures, LDV Partners, Acadia Woods Partners, Casdin Capital, Bay City Capital
Last update: April 1, 2018